The WasteWatcher
The WasteWatcherEl Paso Voters Should Reject Climate Charter
El Pasoans should reject an effort to adopt a "climate charter" for the city.
The WasteWatcherFlorida’s So-Called Data Privacy Bills Will Devastate the Economy
A new law could prevent Florida small businesses from reaching their customers online.
The WasteWatcherNew York Takes the Wrong Approach to Tobacco
New York's proposed tax and flavor ban would negatively impact tobacco harm reduction efforts and public health.
The WasteWatcherCalifornia High-Speed Rail Goes Way Off Track
California’s effort to construct a high-speed rail network was doomed from the start.
The WasteWatcherThe Biden Budget Poses an Existential Threat to the States
The President's proposed budget would distort the balance of power between the federal and state governments.
The WasteWatcherBiden Administration Rejects the F-35 Alternate Engine
The Pentagon was right to fund the JSF engine upgrade and stop the waste of billions of dollars to develop a second engine.
The WasteWatcherThe Cantwell-Grassley PBM Bill is a Wolf in Sheep’s Clothing
A Bill introduced in the Senate takes aim at PBMS and private sector healthcare.
The WasteWatcherHouse Renews Consideration of Privacy Legislation
House subcommittee holds hearing to discuss what should be included in legislation to protect consumer data privacy.
The WasteWatcherReynolds Offers Plan to Reduce Waste and Increase Efficiency in Iowa Government
Gov. Reynolds' proposals aim to reduce inefficiency while reducing the regulatory burden on taxpayers.
The WasteWatcherGAO Audit Finds Serious Issues in Financial Management
Major issues continue to plague the government's finances and demonstrates the need for oversight and accountability.
The WasteWatcherLas Vegas Should be Wary of a Deal for the Athletics
Las Vegas should resist any efforts by the Oakland Athletics to gain public funding for the construction of a new stadium.
The WasteWatcherPatients Pay the Ultimate Price for Price Controls
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
